Array Market
A DNA microarray, often known as a chip, is a semiconductor surface on which probes are connected to sequences of many different genes. DNA microarrays are used to concurrently quantify the expression levels of a large number of genes or genotype numerous sections of a genome. The method can be used in medication development, clinical diagnostics, agriculture, environmental control, and other fields.
Over the projection period, the global Array Market (life science and biotechnology instruments) is expected to rise due to the high prevalence of cancer. According to the American Cancer Society, there will be 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States year 2019. Furthermore, over the projected period, the worldwide array market (life science and biotechnology instruments) is expected to rise due to the increasing popularity of genetic testing. For example, in April 2020, Axovant Gene Therapies partnered with Invitae Corporation, a supplier of advanced medical genetics, to offer free genetic testing for juvenile lysosomal storage disorder in the United States and Canada.
Market Segmentation:
By Type
- DNA Array
- Protein Array
- Tissue Array
- Cell Array
By End User
- Biopharmaceutical and Pharmaceutical
- Diagnostic Laboratories
- Research Laboratories
- Others
Cancer R&D is predicted to provide lucrative growth possibilities for global array market competitors (life science and biotechnology instruments). Researchers from Taiwan's National Defense Medical Center, for example, reported using DNA microarray gene expression profiles to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages in April 2020.
The major players operating in the global array market (life science and biotechnology instruments) include, Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
